Please login to the form below

Not currently logged in
Email:
Password:

Three questions that should anchor your brand strategy

Ensuring the organisation is focused on pursuing the most attractive commercial opportunities

Ed Corbett

'Strategy’ is a word that is often overused and can mean different things to different people. At its most basic, it is about making informed choices to achieve an agreed ambition, enabling resources to be deployed towards areas of greatest opportunity. The absence of a sound strategy typically leads to chaos and poor performance.

Most pharmaceutical companies have a process that cascades the corporate strategy through the organisation and enables the creation of tailored strategies in R&D, commercial and manufacturing. This ensures alignment across the organisation with the overall strategic direction and goals. Such a process often leverages templates to capture relevant insights to enable decision-making. However, templates are often used too rigidly, which risks limiting thinking and creating a box-ticking mentality. Many a team has filled them in ‘just to secure next year’s budget’.

The rigid use of templates in brand strategy creation means organisations miss a huge opportunity. A great brand planning process should be embraced as a time to pause and really think about a product’s future, make informed decisions that will benefit patients and deliver revenue for the company. Templates are simply tools to enable the right conversations and ensure key decisions are taken.

Commercial leaders have a critical role to play in the strategic planning process. They should provide guidance on how to get the most from any tools or templates, and focus teams on the things that really matter, such as gaining customer insight, competitive planning and making the most of new indications.

Setting strategy can seem daunting, complex and confusing. There is so much to consider and so many potential opportunities to pursue. As the fog of confusion clears and choices are made, commercial leaders and their teams should be anchored to three questions:

1) Who are our target customers (patients, physicians, payers) and why?

2) What do we want them to do differently and why?

3) How are we going to make this happen? Although simple, they are powerful checks that ensure the organisation is focused on pursuing the most attractive commercial opportunities.

Ed Corbett is a Partner at Novasecta, Europe’s leading pharmaceutical strategy consultancy

In association with

Novasecta

18th March 2019

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics